Genetic Engineering Dangers

I want to thank The Scientist for reporting on my return of a $613,882 grant to the National Institutes of Health in the Dec. 12, 1994, issue (Notebook, page 4). However, the story missed the real purpose for my action--to bring attention to the dangers of the environmental release of genetically altered organisms and of germ-line genetic manipulations in humans. I also announced that I was redirecting my own research to traditional medical systems, particularly Maharishi Ayur-Veda, a preventio

Written byJohn Fagain
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I want to thank The Scientist for reporting on my return of a $613,882 grant to the National Institutes of Health in the Dec. 12, 1994, issue (Notebook, page 4).

However, the story missed the real purpose for my action--to bring attention to the dangers of the environmental release of genetically altered organisms and of germ-line genetic manipulations in humans. I also announced that I was redirecting my own research to traditional medical systems, particularly Maharishi Ayur-Veda, a prevention-oriented, natural medical system that shows great potential.

Science should be guiding the implementation of genetic technologies. We should not allow economic and political pressures to capitalize on these technologies at the expense of health or the environment.

In many cases, knowledgeable scientists have been ignored when they have raised legitimate concerns. This was the case in December, when the United States Department of Agriculture ignored the warnings of many experts and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies